Archive of past meetings and training schools
List of meetings and training schools
Oxygen in Health and Disease
Location: Smolenice, Slovakia
Oxygen is increasingly recognized as a critical regulator of many biological processes at the molecular, cellular and tissue levels. Imbalances in its supply and/or consumption are linked with many pathological situations. Among others, brain and heart ischemia-related diseases and cancer progression are particularly linked with perturbed oxygen signalling and metabolism. The proposed conference is intended to cover all important aspects of the oxygen involvement in biochemical and molecular pathways, cell behavior, development, tissue functioning, and diseases. The satellite symposium “Oxygen in Health and Disease” offers an exciting scientific program and we look forward to your participation.
REGISTRATION DATE EXTENDED TO MARCH 19, 2010.
Working Group meeting - Therapeutic aspects of hypoxia-dependent pathways.
Location: UCD Conway Institute, Dublin, Ireland.
When oxygen availability is reduced, inherent physiologic responses are initiated through both cellular as well as systemic mechanisms. Hypoxia plays a crucial role in almost all acute and chronic diseases including, but not limited to, kidney and liver diseases, pulmonary hypertension, most forms of cardiovascular disease, retinal degeneration, wound healing, CNS pathologies, ischemia, inflammation, transplantation, acute or chronic mountain sickness and cancer. The Dublin Working Group meeting is dedicated to discussing and presenting the latest research in relation to “Therapeutic aspects of Hypoxia-inducible pathways”. This two day meeting will have four sessions dealing with Basic Science, Technology, Pharmacology and Translational Medicine of this hot topic in Hypoxia research.
Location: Davos, Switzerland
When oxygen availability is reduced, inherent physiologic responses are initiated through both cellular as well as systemic mechanisms. Hypoxia plays a crucial role in almost all acute and chronic diseases including, but not limited to, kidney and liver diseases, pulmonary hypertension, most forms of cardiovascular disease including atherosclerosis, stroke, ischemic diseases, retinal degeneration, wound healing, several pathologies of the CNS, inflammation, transplantation, acute or chronic mountain sickness and - last but not least- tumorigenesis. OXYGEN 2011 brings together basic researchers working in the field of molecular hypoxia with their colleagues examining the hypoxic response in human volunteers and patients.
The impact of hypoxia on cells, mice and men
Location: Monte Verità, Ascona, Switzerland
How do we cope with reduced oxygenation (hypoxia)? While hypoxic conditions occurring at high altitude lead to acclimatization processes, more severe conditions require intense responses to minimize tissue damage. Once again, our Monte Verità meeting will emphasize the importance of linking molecular aspects of hypoxia to relevant physiological and pathological aspects of human medicine. Distinguished speakers will give us an overview of the current knowledge in the field and highlight new discoveries. Moreover, in two consensus sessions an expert panel will present and discuss aspects on high altitude pulmonary edema (HAPE) and doping in elite climbers. Special emphasis is also given to the emerging role of hypoxia in inflammatory and degenerative disorders.
Note that this is a small meeting limited to a maximum of 100 participants (including speakers) that will allow intensive discussions.
Hypoxia day in Nantes
Location: Nantes, France
Learning from hypoxia signalling
Location: Bilbao, Spain
Oxygen homeostasis breakdown and associated hypoxia occur in a wide range of physio-pathological conditions, including, but not limited to, embryonic development, high altitude, wound healing, inflammation, ischemic diseases and cancer. A detailed understanding of the signalling cascade triggered by hypoxia is important to exploit this pathway for therapeutic applications.“Learning from Hypoxia signalling”, held in Bilbao, covers four sessions dealing with hypoxia sensing and signalling, stem cells behaviour, metabolic control and translational research. The goal of this meeting highlights the most recent progress in the field and provides a unique framework for discussion and interaction between all the participants.
Players of the Epigenetic Symphony
Location: Poitiers, France
Epigenetics focuses on environmental, nutritional and (bio)chemical factors influencing gene expression, in the absence of changes in DNA sequence. This meeting is proposed to young and confirmed scientists wanting to increase their knowledge in this field. For scientists already involved in epigenetics, this is an opportunity to acquire knowledge on other scientific strategies developed to unravel the functional impact of epigenetic mechanisms. The workshop will include presentations on: design of inhibitors to epigenetic targets, methods for measuring epigenetic activities, epigenetic protein interactions and functional impact of epigenetic modifications. (Download the flyer at the bottom).
TD0901 can support some Trainees to attend this Training School
Pathophysiology and Pharmacology of Erythropoietin and other Hemopoietic Growth Factors
Location: Luebeck, Germany
Sensing Hypoxia in the Cell and the Organism
Location: Essen, Germany
Why should I attend this meeting?
Cells and tissues of the organism require oxygen for survival and proper function. Hypoxia occurs when the balance between oxygen supply and demand is lost, either due to reduced supply or to increased demand. Tissues and cells in particular have to sense changes in oxygen tension to recognize hypoxia in order to initiate adequate cellular responses. This chain of events - sensing oxygen levels - transduction into cellular signals - initiation of an adequate response - is essential for physiology and pathophysiology likewise. Thus, ischemic disease, tumor biology but also wound healing and proper embryonic development from stem cells to a functioning organism are fields where the understanding of hypoxia sensing is fundamental.
The goal of this meeting is to focus on recent highlights in the field of oxygen sensing in health and disease from cells to whole organisms.
Dealing with hypoxia: Regulatory aspects in cells, tissues and organisms
Location: Oulu, Finland
Hypoxia can be life threatening – for cells and the organism. To adequately respond to the shortage of oxygen cells have to sense changes in their ambient oxygen concentration. How are changes in a physical parameter, i.e. the pO2, translated into a biological response such as modulation of gene expression?
The aim of the meeting is to highlight and discuss the latest developments in the broad field of hypoxia response. The TD0901 COST Action formed by European scientists and funded by the European Union started in November 2009 and will end in November 2013. This is the second international congress arranged by the network following the Oxygen 2011 meeting in Davos, Switzerland.
The program of the Oxygen 2013 meeting will include invited keynote lectures, invited lectures, short talks selected from submitted abstracts and a training school session. All submitted abstracts will be presented as posters.
Seville Molecular Medicine Workshops. Hypoxia, Molecular Mechanisms and Clinical Translations
Location: Seville, Spain
Hypoxia: From Basic Mechanisms to Therapeutics (E3)
Location: Dublin, Ireland
Tissue hypoxia occurs in a range of physiologic and pathophysiologica states. Consequently, the cellular response to hypoxia has important implications for both health and diseases including (but not limited to) cancer, ischemia and chronic inflammation. Recently, the discovery and elucidation of specific hypoxia-inducible pathways has raised the possibility of developing new strategies for therapeutic benefit based on targeting hypoxia-sensitive pathways. The aim of this meeting is to disseminate up to date information on basic mechanisms of the cellular hypoxic response, discuss the impact of this response for health and disease and highlight the potential for developing new therapeutics based on our understanding of the pathways involved. It is anticipated that outcomes of this meeting will include the dissemination of new scientific knowledge, the discussion of new methodologies, the education of graduate students and fellows in the state-of-the-art and promoting new collaborations between clinicians, basic researchers and industrial partners. The Keystone Symposia Hypoxia meeting is widely accepted as the world´s leading conference addressing the topic and is a key date on the calendar for all researchers interested in this topic. We will bring together academic, clinical and industrial researchers to drive synergy through collaboration in developing the translational potential of targeting the HIF pathway for therapeutic benefit. This meeting will be a joint meeting between the HypoxiaNET consortium and Keystone Symposia.